Prolyl oligopeptidase activity (POP) in early stage and medicated schizophrenia and in an animal model for schizophrenia study: In vivo effects of psychopharmacological substances on enzyme activity
Prolyl oligopeptidase (POP) is an enzyme highly expressed in the central nervous system, playing important roles in neurodevelopment, memory and learning. Moreover, changes in POP activity in peripheral blood have been associated with various neuropsychiatric disorders. Herein, the POP activity was...
Main Authors: | Lucas A.N. Marins, Benjamín Rodríguez, João V. Nani, Vitor Oliveira, Ary Gadelha, Mirian A.F. Hayashi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-06-01
|
Series: | Brain Disorders |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666459323000124 |
Similar Items
-
Computational analysis of human gut microbial prolyl oligopeptidases (POPs) reveal candidate genes as therapeutics for celiac disease
by: Soumya Nayak, et al.
Published: (2024-08-01) -
The Inhibition of Prolyl Oligopeptidase as New Target to Counteract Chronic Venous Insufficiency: Findings in a Mouse Model
by: Giovanna Casili, et al.
Published: (2020-12-01) -
Effect of chiral silver nanoparticles on prolyl-oligopeptidase binding and activity
by: Carin C. S. Batista, et al.
Published: (2024-07-01) -
Prolyl oligopeptidase inhibition ameliorates experimental pulmonary fibrosis both in vivo and in vitro
by: Laura Cucinotta, et al.
Published: (2023-08-01) -
Abnormal Expression of Prolyl Oligopeptidase (POP) and Its Catalytic Products Ac-SDKP Contributes to the Ovarian Fibrosis Change in Polycystic Ovary Syndrome (PCOS) Mice
by: Suo Han, et al.
Published: (2023-07-01)